Cancer research startup Juno Therapeutics raises $120M in massive series A financing

In one of the largest series A venture capital deals this year in the biotechnology sector, Seattle-based Juno Therapeutics has landed $120 million in startup financing in a deal led by Arch Venture Partners and the Alaska Permanent Fund. The cancer research company is a spin out of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer… Read More